<DOC>
	<DOCNO>NCT00571844</DOCNO>
	<brief_summary>This study NIH-funded clinical trial conduct Duke Medical Center evaluate effect DASH diet alone combine behavioral weight loss program blood pressure various vascular measure . Eligible patient must unmedicated blood pressure value range approximately 130/85 159/99 . Our primary hypothesis follow : ( 1 ) The DASH diet alone combined behavioral weight management program result great BP reduction Usual Care control end 4 month treatment period ; ( 2 ) The DASH diet combination behavioral weight management program effective lower BP DASH diet alone ; ( 3 ) The DASH diet alone DASH diet combine behavioral weight management program result great improvement cardiac , metabolic , vascular function compare control condition ; ( 4 ) The combined DASH diet weight management intervention also effective treatment maintain BP reduction 1-year follow-up .</brief_summary>
	<brief_title>ENCORE : Exercise Nutritional Interventions Cardiovascular Health</brief_title>
	<detailed_description>The present application seek extend previous finding ) evaluate efficacy DASH diet free-living situation ; ( b ) consider DASH diet alone combination behavioral weight loss program include aerobic exercise ; ( c ) examine impact diet exercise cardiac , metabolic , vascular function , include measure arterial stiffness , endothelial function , baroreflex control , body composition , insulin resistance , cardiac hemodynamics , leave ventricular ( LV ) geometry mass ; ( ) follow patient one year determine long term impact intervention BP , body weight , cardiovascular function .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>1 . Baseline SBP 130159 mmHg ( +/ 2mmHg ) DBP 8599 mmHg ( +/ 2 mm Hg ) 2 . Age 35 year old 3 . BMI 25.039.99 kg/mÂ² , maximum weight 300 lbs 4 . Willing able participate fully aspects intervention 5 . Must currently sedentary ( less 3x/wk 30 min time ) 6 . Informed consent 1 . Use weightloss medication and/or participation structure weight loss program 3 month prior 1st screen visit . 2 . Regular use antihypertensive drug drug raise low BP discontinue use , must 1 month screen 3 . Current use insulin oral hypoglycemic agent 4 . Current use medication treatment psychosis manicdepressive illness . 5 . ADHD medication ( Ritalin/Aderol/amphetamines 6 . Cardiovascular Event 7 . Coronary Artery Disease 8 . Congestive Heart Failure 9 . Current symptom Angina peripheral vascular disease 10 . Cancer diagnosis ( except nonmelanoma skin cancer ) treatment past 2 year 11 . Fasting blood sugar &gt; 126 mg/dl 12 . Gastric Bypass/Bariatric Surgery 13 . Pyschiatric hospitalization past 2 year . 14 . Unable willing consume dietary food provide 2week feeding . 15 . Consumption 21 alcoholic drink per week binge drink 16 . Alcoholism determine Alcohol AUDIT ( screen questionnaire ) 17 . Planning leave area prior anticipated end participation 18 . Body weight change &gt; 15lbs 3 month prior 1st screen visit 19 . Pregnant , breast feeding , plan pregnancy prior end participation 20 . Current participation another clinical trial completion T2 21 . Investigator discretion safety adherence reason 22 . Controlled substance abuse</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>High Blood Pressure</keyword>
	<keyword>Exercise</keyword>
	<keyword>Diet</keyword>
	<keyword>Biomarkers</keyword>
</DOC>